|
Fusion gene ID: 9158 |
FusionGeneSummary for CYP2C9_APOH |
Fusion gene summary |
Fusion gene information | Fusion gene name: CYP2C9_APOH | Fusion gene ID: 9158 | Hgene | Tgene | Gene symbol | CYP2C9 | APOH | Gene ID | 1559 | 350 |
Gene name | cytochrome P450 family 2 subfamily C member 9 | apolipoprotein H | |
Synonyms | CPC9|CYP2C|CYP2C10|CYPIIC9|P450IIC9 | B2G1|B2GP1|BG | |
Cytomap | 10q23.33 | 17q24.2 | |
Type of gene | protein-coding | protein-coding | |
Description | cytochrome P450 2C9cytochrome P-450 S-mephenytoin 4-hydroxylasecytochrome P-450MPcytochrome P450 PB-1cytochrome P450, family 2, subfamily C, polypeptide 9flavoprotein-linked monooxygenasemicrosomal monooxygenasexenobiotic monooxygenase | beta-2-glycoprotein 1APC inhibitorB2GPIactivated protein C-binding proteinanticardiolipin cofactorapo-Hapolipoprotein H (beta-2-glycoprotein I)beta(2)GPI | |
Modification date | 20180523 | 20180522 | |
UniProtAcc | P11712 | P02749 | |
Ensembl transtripts involved in fusion gene | ENST00000260682, ENST00000461906, | ENST00000205948, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 2 X 2 X 2=8 |
# samples | 1 | 3 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(3/8*10)=1.90689059560852 | |
Context | PubMed: CYP2C9 [Title/Abstract] AND APOH [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CYP2C9 | GO:0016098 | monoterpenoid metabolic process | 16401082 |
Hgene | CYP2C9 | GO:0017144 | drug metabolic process | 19219744|19651758 |
Hgene | CYP2C9 | GO:0019627 | urea metabolic process | 19029318 |
Hgene | CYP2C9 | GO:0032787 | monocarboxylic acid metabolic process | 19651758 |
Hgene | CYP2C9 | GO:0042738 | exogenous drug catabolic process | 18619574 |
Hgene | CYP2C9 | GO:0043603 | cellular amide metabolic process | 19651758 |
Hgene | CYP2C9 | GO:0055114 | oxidation-reduction process | 16401082|19219744 |
Hgene | CYP2C9 | GO:0070989 | oxidative demethylation | 18619574 |
Tgene | APOH | GO:0001937 | negative regulation of endothelial cell proliferation | 17872974 |
Tgene | APOH | GO:0006641 | triglyceride metabolic process | 7417307 |
Tgene | APOH | GO:0007597 | blood coagulation, intrinsic pathway | 4052628 |
Tgene | APOH | GO:0010596 | negative regulation of endothelial cell migration | 17872974 |
Tgene | APOH | GO:0016525 | negative regulation of angiogenesis | 17872974 |
Tgene | APOH | GO:0030195 | negative regulation of blood coagulation | 4052628 |
Tgene | APOH | GO:0031639 | plasminogen activation | 16480936 |
Tgene | APOH | GO:0033033 | negative regulation of myeloid cell apoptotic process | 15534879 |
Tgene | APOH | GO:0034392 | negative regulation of smooth muscle cell apoptotic process | 15534879 |
Tgene | APOH | GO:0051006 | positive regulation of lipoprotein lipase activity | 7417307 |
Tgene | APOH | GO:0051917 | regulation of fibrinolysis | 16480936 |
Tgene | APOH | GO:0051918 | negative regulation of fibrinolysis | 14726399 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LIHC | TCGA-DD-AAE2-01A | CYP2C9 | chr10 | 96749447 | + | APOH | chr17 | 64225556 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000260682 | ENST00000205948 | CYP2C9 | chr10 | 96749447 | + | APOH | chr17 | 64225556 | - |
intron-intron | ENST00000461906 | ENST00000205948 | CYP2C9 | chr10 | 96749447 | + | APOH | chr17 | 64225556 | - |
Top |
FusionProtFeatures for CYP2C9_APOH |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CYP2C9 | APOH |
Cytochromes P450 are a group of heme-thiolatemonooxygenases. In liver microsomes, this enzyme is involved in anNADPH-dependent electron transport pathway. It oxidizes a varietyof structurally unrelated compounds, including steroids, fattyacids, and xenobiotics (PubMed:25994031). This enzyme contributesto the wide pharmacokinetics variability of the metabolism ofdrugs such as S-warfarin, diclofenac, phenytoin, tolbutamide andlosartan (PubMed:25994031). {ECO:0000269|PubMed:25994031}. | Binds to various kinds of negatively charged substancessuch as heparin, phospholipids, and dextran sulfate. May preventactivation of the intrinsic blood coagulation cascade by bindingto phospholipids on the surface of damaged cells. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CYP2C9_APOH |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CYP2C9_APOH |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CYP2C9 | POR, CDC37, MAST1, RAB3D, RNF32, ECSIT, CYP2D6, STAT5A, STAMBP, CYP2C18, CYP3A4, CYP2C19, CD97, TOMM40 | APOH | LRP8, LRP2, ANXA2, AKT1, CLEC4G, GRB2, TP53, GEM, CDC42, RBBP6, ATP4A, FLNA |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CYP2C9_APOH |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | CYP2C9 | P11712 | DB11994 | Diacerein | Cytochrome P450 2C9 | small molecule | approved|investigational |
Top |
RelatedDiseases for CYP2C9_APOH |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CYP2C9 | C0019080 | Hemorrhage | 4 | CTD_human |
Hgene | CYP2C9 | C0041696 | Unipolar Depression | 4 | PSYGENET |
Hgene | CYP2C9 | C1269683 | Major Depressive Disorder | 4 | PSYGENET |
Hgene | CYP2C9 | C0041755 | Adverse reaction to drug | 2 | CTD_human |
Hgene | CYP2C9 | C4277682 | Chemical and Drug Induced Liver Injury | 2 | CTD_human |
Hgene | CYP2C9 | C0006118 | Brain Neoplasms | 1 | CTD_human |
Hgene | CYP2C9 | C0013182 | Drug Allergy | 1 | CTD_human |
Hgene | CYP2C9 | C0027707 | Nephritis, Interstitial | 1 | CTD_human |
Hgene | CYP2C9 | C0027765 | nervous system disorder | 1 | CTD_human |
Hgene | CYP2C9 | C0030922 | Peptic Ulcer Hemorrhage | 1 | CTD_human |
Hgene | CYP2C9 | C0878544 | Cardiomyopathies | 1 | CTD_human |
Hgene | CYP2C9 | C2609414 | Acute kidney injury | 1 | CTD_human |
Tgene | APOH | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | APOH | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |